Cargando…

World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer

Detalles Bibliográficos
Autor principal: Liu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772009/
https://www.ncbi.nlm.nih.gov/pubmed/33392608
http://dx.doi.org/10.1055/s-0040-1721451
_version_ 1783629786334101504
author Liu, Qian
author_facet Liu, Qian
author_sort Liu, Qian
collection PubMed
description
format Online
Article
Text
id pubmed-7772009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-77720092020-12-31 World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer Liu, Qian Glob Med Genet Georg Thieme Verlag KG 2020-10 2020-12-07 /pmc/articles/PMC7772009/ /pubmed/33392608 http://dx.doi.org/10.1055/s-0040-1721451 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Liu, Qian
World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title_full World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title_fullStr World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title_full_unstemmed World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title_short World-First Phase I Clinical Trial for CRISPR-Cas9 PD-1-Edited T-Cells in Advanced Nonsmall Cell Lung Cancer
title_sort world-first phase i clinical trial for crispr-cas9 pd-1-edited t-cells in advanced nonsmall cell lung cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772009/
https://www.ncbi.nlm.nih.gov/pubmed/33392608
http://dx.doi.org/10.1055/s-0040-1721451
work_keys_str_mv AT liuqian worldfirstphaseiclinicaltrialforcrisprcas9pd1editedtcellsinadvancednonsmallcelllungcancer